 |
|
BREAZE L |
|
Composition |
Each uncoated mouth dissolving bi-layered tablet
contains Montelukast Sodium IP equivalent to Montelukast 10mg. Levocetirizine HCl IP - 5mg. |
|
Therapeutic Area |
For relief of symptoms of co-morbid allergic
rhinitis and asthma, seasonal and perennial allergic rhinitis, atopic dermatitis and chronic idiopathic urticaria. |
|
Dosage form |
Oral solids (tablets) |
|
Pack Size |
: 10 X 10's |
|
|
 |
|
BREAZE L KID |
|
Composition |
Each uncoated dispersible tablet contains Montelukast Sodium IP equivalent to Montelukast 4mg. Levocetirizine HCl IP - 2.5mg. |
|
Therapeutic Area |
For relief of symptoms of co-morbid allergic
rhinitis and asthma, seasonal and perennial allergic rhinitis, atopic dermatitis and
chronic idiopathic urticaria |
|
Dosage form |
Oral solids (tablets) |
|
Pack Size |
: 10 X 10's |
|
|
 |
|
BREAZE 5 |
|
Composition |
Each uncoated mouth dissolving tablet contains Montelukast Sodium IP equivalent to Montelukast 5mg. |
|
Therapeutic Area |
Prophylaxis and chronic treatment of asthma, acute
prevention of exercise-inducedbronchoconstriction, relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients and perennial allergic rhinitis (PAR) in patients 6 months of age and older |
|
Dosage form |
Oral solids (tablets) |
|
Pack Size |
10 X 10's |
|
|
 |
|
ANAFLAM XP |
|
Composition |
Each uncoated mouth dissolving tablet contains Montelukast Sodium IP equivalent to Montelukast 10mg. |
|
Therapeutic Area |
Prophylaxis and chronic treatment of asthma, acute
prevention of exercise-induced bronchoconstriction, relief of symptoms of allergic rhinitis (AR) : seasonal allergic rhinitis (SAR) in patients and perennial allergic rhinitis (PAR) in patients 6 months of age and older |
|
Dosage form |
Oral solids (tablets) |
|
Pack Size |
10 X 10's |
|
|
|
|
Quick Links of Other Oral
|
